Cargando…

Gut microbiota and cerebrovascular diseases: a Mendelian randomization study

BACKGROUND: The causal relationship between gut microbiota and cerebrovascular disease remains unknown, despite several recent studies reporting an association between the two. METHODS: To assess this relationship, we conducted a two-sample Mendelian randomization (MR) using summary statistics data...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Hao, Yang, Fan, Hao, Pengfei, Zhang, Xianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448814/
https://www.ncbi.nlm.nih.gov/pubmed/37637136
http://dx.doi.org/10.3389/fmicb.2023.1228815
_version_ 1785094814487805952
author Qin, Hao
Yang, Fan
Hao, Pengfei
Zhang, Xianfeng
author_facet Qin, Hao
Yang, Fan
Hao, Pengfei
Zhang, Xianfeng
author_sort Qin, Hao
collection PubMed
description BACKGROUND: The causal relationship between gut microbiota and cerebrovascular disease remains unknown, despite several recent studies reporting an association between the two. METHODS: To assess this relationship, we conducted a two-sample Mendelian randomization (MR) using summary statistics data from published genome-wide association studies (GWAS). This analysis allowed us to identify bacterial taxa that may affect cerebrovascular disease. Furthermore, we performed reverse MR to further analyze the significant bacterial taxa. Finally, we conducted a two-step MR analysis to examine the mediating role of metabolic factors [systolic blood pressure (SBP), type 2 diabetes (T2D), and body mass index (BMI)] in the association between gut microbiota and cerebrovascular disease. Additionally, a series of sensitivity analyses were carried out to validate the robustness of our findings. RESULTS: Our results showed that a genetically predicted high abundance of family Porphyromonadaceae reduced the risk of intracranial aneurysms (IA). Moreover, using inverse variance weighted (IVW) estimates, we found a nominal causal relationship between seventeen gut microbiota and IA, as well as its subtypes. In the case of stroke and its subtypes, we observed a nominal causal relationship with thirteen, eleven, eleven, nine, and eight bacteria for AS, AIS, CES, LAS, and SVS, respectively. Reverse MR analysis showed no significant causal relationship between intracranial aneurysms and gut microbiota. However, we did find that genetically predicted any stroke (AS) and any ischemic stroke (AIS) reduced the abundance of family Clostridiaceae1 (OR: 0.74, 95% CI: 0.62–0.87, p = 3.39 × 10(−4), and OR: 0.75, 95% CI: 0.66–0.87, p = 7.06 × 10(−5), respectively). Furthermore, genetic prediction of AIS (OR: 0.87, 95% CI: 0.77–0.99, p = 3.05 × 10(−2)) was associated with a reduced abundance of the order Clostridiales. Moreover, genus Streptococcus exhibited effects on AS, AIS, and SVS which were mediated by T2D. Conversely, the association between genus Eubacterium brachy group and AIS was mediated by SBP. No significant heterogeneity of instrumental variables or horizontal pleiotropy was observed. CONCLUSION: This MR analysis indicates that there exists a beneficial or detrimental causal effect of gut microbiota composition on cerebrovascular disease. And SBP and T2D may play mediating role in this process.
format Online
Article
Text
id pubmed-10448814
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104488142023-08-25 Gut microbiota and cerebrovascular diseases: a Mendelian randomization study Qin, Hao Yang, Fan Hao, Pengfei Zhang, Xianfeng Front Microbiol Microbiology BACKGROUND: The causal relationship between gut microbiota and cerebrovascular disease remains unknown, despite several recent studies reporting an association between the two. METHODS: To assess this relationship, we conducted a two-sample Mendelian randomization (MR) using summary statistics data from published genome-wide association studies (GWAS). This analysis allowed us to identify bacterial taxa that may affect cerebrovascular disease. Furthermore, we performed reverse MR to further analyze the significant bacterial taxa. Finally, we conducted a two-step MR analysis to examine the mediating role of metabolic factors [systolic blood pressure (SBP), type 2 diabetes (T2D), and body mass index (BMI)] in the association between gut microbiota and cerebrovascular disease. Additionally, a series of sensitivity analyses were carried out to validate the robustness of our findings. RESULTS: Our results showed that a genetically predicted high abundance of family Porphyromonadaceae reduced the risk of intracranial aneurysms (IA). Moreover, using inverse variance weighted (IVW) estimates, we found a nominal causal relationship between seventeen gut microbiota and IA, as well as its subtypes. In the case of stroke and its subtypes, we observed a nominal causal relationship with thirteen, eleven, eleven, nine, and eight bacteria for AS, AIS, CES, LAS, and SVS, respectively. Reverse MR analysis showed no significant causal relationship between intracranial aneurysms and gut microbiota. However, we did find that genetically predicted any stroke (AS) and any ischemic stroke (AIS) reduced the abundance of family Clostridiaceae1 (OR: 0.74, 95% CI: 0.62–0.87, p = 3.39 × 10(−4), and OR: 0.75, 95% CI: 0.66–0.87, p = 7.06 × 10(−5), respectively). Furthermore, genetic prediction of AIS (OR: 0.87, 95% CI: 0.77–0.99, p = 3.05 × 10(−2)) was associated with a reduced abundance of the order Clostridiales. Moreover, genus Streptococcus exhibited effects on AS, AIS, and SVS which were mediated by T2D. Conversely, the association between genus Eubacterium brachy group and AIS was mediated by SBP. No significant heterogeneity of instrumental variables or horizontal pleiotropy was observed. CONCLUSION: This MR analysis indicates that there exists a beneficial or detrimental causal effect of gut microbiota composition on cerebrovascular disease. And SBP and T2D may play mediating role in this process. Frontiers Media S.A. 2023-08-10 /pmc/articles/PMC10448814/ /pubmed/37637136 http://dx.doi.org/10.3389/fmicb.2023.1228815 Text en Copyright © 2023 Qin, Yang, Hao and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Qin, Hao
Yang, Fan
Hao, Pengfei
Zhang, Xianfeng
Gut microbiota and cerebrovascular diseases: a Mendelian randomization study
title Gut microbiota and cerebrovascular diseases: a Mendelian randomization study
title_full Gut microbiota and cerebrovascular diseases: a Mendelian randomization study
title_fullStr Gut microbiota and cerebrovascular diseases: a Mendelian randomization study
title_full_unstemmed Gut microbiota and cerebrovascular diseases: a Mendelian randomization study
title_short Gut microbiota and cerebrovascular diseases: a Mendelian randomization study
title_sort gut microbiota and cerebrovascular diseases: a mendelian randomization study
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448814/
https://www.ncbi.nlm.nih.gov/pubmed/37637136
http://dx.doi.org/10.3389/fmicb.2023.1228815
work_keys_str_mv AT qinhao gutmicrobiotaandcerebrovasculardiseasesamendelianrandomizationstudy
AT yangfan gutmicrobiotaandcerebrovasculardiseasesamendelianrandomizationstudy
AT haopengfei gutmicrobiotaandcerebrovasculardiseasesamendelianrandomizationstudy
AT zhangxianfeng gutmicrobiotaandcerebrovasculardiseasesamendelianrandomizationstudy